期刊文献+

脑源性神经营养因子基因多态性与精神分裂症的关联研究 被引量:3

Association study of brain-derived neurotrophic factor(BDNF)gene polymorphism in patients with schizophrenia
下载PDF
导出
摘要 目的:探讨脑源性神经营养因子(BDNF)基因多态性与精神分裂症的关联性。方法:以111例精神分裂症发作期患者与362例正常对照为研究对象,通过TaqM an探针单核苷酸多态性(SNP)基因分型技术对BDNF基因及基因上游10 kb区域的标签SNPs rs6265和rs11030101进行基因分型,比较各组间基因型、等位基因及联合基因型分布频率。结果:精神分裂症患者(n=107)与正常对照(n=357)的SNPs rs6265和rs11030101基因型、等位基因及联合基因型分布频率差异无统计学意义;患者发病年龄、不同临床分型与正常对照的基因型、联合基因型之间比较差异无统计学意义。治疗4周后,SNPrs6265的G/G型、G/A型及A/A型阳性与阴性症状量表(PANSS)阴性分量表分依次为(16.38±8.17)、(12.63±4.32)及(12.60±5.08)(F=3.442,P=0.037)。治疗4周个人和社会功能量表(PSP)评分的升幅依次为(37.60±17.96),(25.25±19.18)及(22.90±15.44)(F=4.129,P=0.020)。结论:精神分裂症患者SNPs rs6265和rs11030101基因多态性与精神分裂症发病年龄、临床分型、急性期症状无关,但rs6265的A/A基因型患者在治疗后阴性症状及社会功能的改善较其他基因型患者显著。 Objective: To investigate the association between brain-derived neurotrophic factor(BDNF) gene polymorphisms and the onset age as well as levels of clinical symptoms in patients with schizophrenia. Method:A hundred and eleven patients were included with informed consent.80 eligible patients entered into the 4-week treatment study and the serum BDNF,the positive and negative syndrome scale(PANSS) and the personal and social performance scale(PSP)were assessed before and after treatment.The BDNF polymorphism(rs6265 and rs11030101)was genotyped using a taqman probe technology.BDNF gene single nucleotide polymorphism(rs6265 and rs11030101)genotypic and allelic distributions were compared with the clinical characters of schizophrenia. Results:The genotypic and allelic distribution of rs6265 and rs11030101 had no relationship with the onset age,gender,type in patients with schizophrenia.The mean scores of PANSS-negative and the improvement scores of the personal and PSP were significantly different among three rs6265 genotypes after 4-week treatment(F=3.442,P=0.037;F=4.129,P=0.020). Conclusion:Schizophrenic patients demonstrate impairments in social function,which could be improved with short-term treatment of antipsychotics.The BDNF gene polymorphism is related to negative symptoms and social function after 4-week antipsychotic treatment.The rs6265 A/A genotype showed significant less negative symptoms and more improvement of social function after treatment.
出处 《临床精神医学杂志》 2011年第2期73-76,共4页 Journal of Clinical Psychiatry
基金 美国Stanley医学研究院基金(021-008)
关键词 脑源性神经营养因子 精神分裂症 单核苷酸多态性 brain-derived neurotrophic factor schizophrenia single nucleotide polymorphisms
  • 相关文献

参考文献10

  • 1Numata S, Ueno S, Iga J, et al. Brain-derived neurotrophic factor (BDNF) Va166Met polymorphism in schizophrenia is associated with age at onset and symptoms[ J]. Nenroscienee Letters, 2006, 401 : 1-5.
  • 2Rosa A, Cuesta MJ, Fatjo-VM, et al. The Va166Met polymorphism of the brain-derived neurotrophic factor gene is associated with risk for psychosis : evidence from a iamily based association study [ J ]. Journal of Neurology, 2005,252 : 833-838.
  • 3Krebs MO, Guillin O, Bourdell MC, et al. Brain-derived neirotrophic factor (BDNF)gene variants association with age at onset and therapeutic response in schizophrenia [ J ]. Molecular Psychiatry, 2000,5:558-562.
  • 4Egan M, Kojima M, Callicot JH, et al. The BDNF val66met poly- morphism affects activity-dependent secretion of BDNF and human memory and hippocampal function[ J ]. Cell ,2003,112:257-269.
  • 5Spalletta G,Morris DW,Angelucci F,et M. BDNF Va166Met poly- morphism is associated with aggressive behavior in schizophrenia [ J ]. European Psychiatry,2010,25:311-313.
  • 6Chen Qing-Ying, Chen Qi, Feng Guo-Yin, et al. Association between the brain-derived neurotrophic factor ( BDNF ) gene and Schizophrenia in the Chinese population [ J]. Neuroscience Letters 2006,397 : 285-290.
  • 7Hyman C, Hofer M, Barde YA,et al. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra [ J ]. Nature, 1991, 350:230-232.
  • 8Hong CJ, Yu YW, Lin CH, et al. An association study of a brain derived neurotrophic factor Va166Met polymorphism and clozapine response of schizophrenic patients [ J ]. Neuroscience Letters,2003, 349:206-208.
  • 9Kane J, Honigfeld G, Singer J, et al. Collaborative Study Group, clozapine for the treatment-resistant schizophrenic [ J ]. Archives of General Psychiatry, 1988,45:789-796.
  • 10Reis H J, Nicolato R, Barbosa LG, et al. Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia [ J ]. Neuroscience Letters, 2008,439 : 157-159.

同被引文献23

  • 1吴岚村,高申荣.利培酮治疗精神分裂症长期疗效临床分析[J].中国民康医学,2009,21(21):2706-2707. 被引量:2
  • 2沈鱼邨,于欣,王祖诉,等.精神病学[M].5版.北京:人民卫生出版社,2009:257—258.
  • 3Nasrallah H, Morosini P, Gagnon DD. Reliability, validity and ability to detect change of the Personal and Social Performance scale in patients with stable schizophrenia[ J]. Psychiatry Res, 2008,161 2) :213 -224.
  • 4Patrick DL, Burns T, Morosini P, et al. Reliability, validity and ability to detect change of the clinician-rated Personal and Social Performance scale in patients with acute symptoms of schizophrenia[ J]. Curr Med Res Opin, 2009,25 (2) : 325 - 338.
  • 5Apiquian R, Elena Ulloa R, Herrera-Estrella M, et al. Validity of the Spanish version of the Personal and Social Performance scale in schizophrenia[ J ]. Schizophr Res, 2009, 112(1 -3) :181 -186.
  • 6杨孔军,刘铁榜,杨海晨,等.早发性精神分裂症治疗效果不佳的相关因素分析[J].山东大学学报(医学版),2011,49(8):100-103.
  • 7牛雅娟,吴承京,吉中孚,等.首发精神分裂症患者认知功能相关因素的5年随访[J].中国临床康复,2005,9(44):89-91.
  • 8Weissman MM,Bland RC,Canino GJ. The cross national epidemiology of obsessive compulsive disorder.The Cross National Collaborative Group[J].Journal of Clinical Psychiatry,1994,(Suppl):5-10.
  • 9Massa SM,Yang T,Xie Y. Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents[J].Journal of Clinical Investigation,2010.1774-1785.
  • 10Wendland JR,Kruse MR,Cromer KC. A large case-control study of common functional SLC6A4 and BDNF variants in obsessive-compulsive disorder[J].Neuropsychopharmacology:Official Publication of the American College of Neuropsychopharmacology,2007.2543-2551.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部